| Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses. | |
| | |
MedLine Citation:
|
PMID: 21905942 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: FlexTouch® (FT; Novo Nordisk A/S, Bagsvaerd, Denmark) is a new prefilled insulin pen that has no push-button extension and low injection force. This multi-centre, crossover usability study evaluated the perceptions of, and preference for, FT versus another widely used prefilled pen, SoloStar® (SS; Sanofi, Paris, France), by people with diabetes and healthcare professionals. RESEARCH DESIGN AND METHODS: Following instruction, participants performed injections into a foam cushion, randomly alternating between doses of 20, 40 and 80 international units (IU). Participants then answered questions on usability and preference. RESULTS: In all, 59 people with diabetes and 61 healthcare professionals (30 physicians and 31 nurses) took part. Overall, significantly more respondents preferred to use FT than SS (83 vs 10%, respectively), found FT easier to use (83 vs 9%) and would recommend FT to others (83 vs 8%; p < 0.001 for all). More respondents found it 'very/fairly easy' to reach the push-button and to inject 20, 40 and 80 IU with FT (93, 90 and 88% to inject, respectively) than with SS (73, 43 and 15% to inject, respectively; p < 0.001 for all). Most respondents chose FT as giving them the most confidence in correct and complete insulin delivery (76 vs 6%; p < 0.001) and considerably more were 'very/rather confident' in managing their daily insulin injections with FT than with SS (88 vs 58%). CONCLUSIONS: Most participants rated FT as easier to use and to inject with, were more confident in its accuracy of insulin delivery and preferred it to SS. |
| | |
Authors:
|
David Oyer; Parth Narendran; Marianne Qvist; Marcus Niemeyer; Daniel A Nadeau |
Publication Detail:
|
Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't Date: 2011-09-12 |
Journal Detail:
|
Title: Expert opinion on drug delivery Volume: 8 ISSN: 1744-7593 ISO Abbreviation: Expert Opin Drug Deliv Publication Date: 2011 Oct |
Date Detail:
|
Created Date: 2011-09-21 Completed Date: 2012-01-26 Revised Date: 2012-03-06 |
Medline Journal Info:
|
Nlm Unique ID: 101228421 Medline TA: Expert Opin Drug Deliv Country: England |
Other Details:
|
Languages: eng Pagination: 1259-69 Citation Subset: IM |
Affiliation:
|
Northwestern University, Feinberg School of Medicine, 211 East Chicago Avenue, Suite 1050, Chicago, IL 60611, USA. d-oyer@northwestern.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Cross-Over Studies Diabetes Mellitus, Type 1 / drug therapy Diabetes Mellitus, Type 2 / drug therapy Female Humans Hypoglycemic Agents / administration & dosage*, therapeutic use Injections, Subcutaneous Insulin / administration & dosage*, therapeutic use Male Middle Aged Nurses Patient Preference* Physicians Syringes Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Hypoglycemic Agents; 0/Insulin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Thymidylate synthase inhibitors for non-small cell lung cancer.
Next Document: Emerging drugs which target the renin-angiotensin-aldosterone system.